Company page
Mustang Bio, Inc.
Mustang Bio, Inc. is a public company traded under the ticker MBIO in the American market. The company has a market capitalization of approximately $4.93 million. Mustang Bio focuses on developing innovative therapies for cancer and rare diseases.
- Ticker
- MBIO:NASDAQ
- Asset type
- Stock
- Market cap
- $4.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD